276 related articles for article (PubMed ID: 1977089)
21. A comparison of nizatidine with the three other histamine receptor antagonists for duodenal ulcer therapy.
Lima M; Holdcroft C
Nurse Pract; 1989 Feb; 14(2):41-2. PubMed ID: 2564655
[TBL] [Abstract][Full Text] [Related]
22. Endoscopic double-blind controlled trial of ranitidine vs placebo in the short-term treatment of duodenal ulcer.
Dobrilla G; de Pretis G; Felder M; Chilovi F
Hepatogastroenterology; 1981 Feb; 28(1):49-52. PubMed ID: 6111528
[TBL] [Abstract][Full Text] [Related]
23. [Nizatidine].
Romero M; Franzosi MG
Medicina (Firenze); 1989; 9(1):93-6. PubMed ID: 2567957
[TBL] [Abstract][Full Text] [Related]
24. Clinical review of histamine2 receptor antagonists.
Lipsy RJ; Fennerty B; Fagan TC
Arch Intern Med; 1990 Apr; 150(4):745-51. PubMed ID: 1970232
[TBL] [Abstract][Full Text] [Related]
25. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
Bardhan KD; Wurzer H; Marcelino M; Jahnsen J; Lotay N; Roberts PM
Am J Gastroenterol; 1998 Mar; 93(3):380-5. PubMed ID: 9517644
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the efficacy and safety of ebrotidine in the treatment of duodenal ulcer. A multicentre, double-blind, placebo-controlled phase II study.
Gabryelewicz A; Czajkowski A; Skrodzka D; Marlicz K; Luca de Tena F; Aldeguer M; Chantar C; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):545-50. PubMed ID: 9205762
[TBL] [Abstract][Full Text] [Related]
27. A comparison of nizatidine and ranitidine in the maintenance treatment of duodenal ulcer. A randomized, double blind, multicentre, 2-year study.
Di Mario F; Battaglia G; Saggioro A; Chiozzini P; D'Angelo A; Marin R; Morelli A; Vezzadini P; Buscarini L; Cavassini G
Ital J Gastroenterol; 1991 Jun; 23(5):253-6. PubMed ID: 1742515
[TBL] [Abstract][Full Text] [Related]
28. [Ranitidine therapy of duodenal ulcer: comparison of once-a-day and twice-a-day administration. A Swiss multicenter double-blind study].
Aenishänslin W; Bergoz R; Capitaine Y; Egger G; Etienne A; Fumagalli I; Güller R; Hammer B; Kobler E; Leuthold E
Schweiz Med Wochenschr; 1986 May; 116(19):637-41. PubMed ID: 3715441
[TBL] [Abstract][Full Text] [Related]
29. Role of histamine-2 receptor antagonists after simple closure of perforated duodenal ulcer--a double blind randomised, controlled study.
Sevvel S; Ananthakrishnan N; Kate V
Trop Gastroenterol; 1996; 17(4):227-9. PubMed ID: 9094865
[TBL] [Abstract][Full Text] [Related]
30. [3 mg telenzepine nocte in the treatment of benign stomach ulcer disease: a double-blind comparative study with 300 mg ranitidine nocte].
Simon B; Reinicke HG; Dammann HG; Müller P
Z Gastroenterol; 1990 Feb; 28(2):90-3. PubMed ID: 2181788
[TBL] [Abstract][Full Text] [Related]
31. Double-blind comparison of the safety and efficacy of famotidine with ranitidine in patients with endoscopically diagnosed peptic ulcer.
Sawant PD; Nanivadekar SA; Patel HD; Shroff CP; Oke VG; Jha RJ; Bowalekar SK; Navani SR; Raghu CN
J Assoc Physicians India; 1990 Sep; 38 Suppl 1():723-6. PubMed ID: 2092029
[TBL] [Abstract][Full Text] [Related]
32. Is the inhibition of nocturnal gastric acid secretion the most important factor in duodenal ulcer treatment? A comparison between the effectiveness of single morning and nocte doses of ranitidine 300 mg.
Zaterka S; Massuda HK; Eisig JN; Chinzon D; Bettarello A
Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(5):185-8. PubMed ID: 2700103
[TBL] [Abstract][Full Text] [Related]
33. Safety of nizatidine in clinical trials conducted in the USA and Europe.
Cloud ML
Scand J Gastroenterol Suppl; 1987; 136():29-36. PubMed ID: 2892253
[TBL] [Abstract][Full Text] [Related]
34. A double-blind controlled trial of ranitidine 300 mg nocte and ranitidine 150 mg b.i.d. in the short-term treatment of gastric ulcer.
Barbara L; Corinaldesi R; Adamo S; Comin V; Dobrilla G; Giacosa A; Ghidini O; Huscher C; Panza E
Int J Clin Pharmacol Ther Toxicol; 1986 Feb; 24(2):104-7. PubMed ID: 3514488
[TBL] [Abstract][Full Text] [Related]
35. Nizatidine versus ranitidine in the prevention of duodenal ulcer relapse. Six-month interim results of a European multicentre study.
Hentschel E; Schütze K; Reichel W; Kerstan E; Kratochvil P; Brandstätter G; Judmaier G; Keohane PP
Scand J Gastroenterol Suppl; 1987; 136():84-8. PubMed ID: 2892260
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of duodenal ulcer with famotidine].
Schütze K; Hentschel E; Reichel W; Kerstan E
Wien Med Wochenschr; 1987 Sep; 137(17):409-11. PubMed ID: 2891224
[TBL] [Abstract][Full Text] [Related]
37. [Comparative efficacy of famotidine and ranitidine in the treatment of acute-phase duodenal ulcer. A French comparative therapeutic trial].
Delvaux M; Hagège CG; Ribet A
Gastroenterol Clin Biol; 1989 Dec; 13(12):1055-9. PubMed ID: 2696659
[TBL] [Abstract][Full Text] [Related]
38. [Modern trends in the treatment of ulcer disease (clinical study of nizatidine "Galitidine")].
Dzambas D; Zivanović M; Majoros J; Petrović Z; Barjaktarović M; Hadnadev L; Tomić Z; Mrda Z; Damjanov D
Med Pregl; 1992; 45(9-10):353-8. PubMed ID: 1344473
[TBL] [Abstract][Full Text] [Related]
39. Prostaglandins and peptic ulcer disease: nocturnal administration of rioprostil vs ranitidine in duodenal ulcer healing.
Simon B; Dammann HG; Müller P
Klin Wochenschr; 1986; 64 Suppl 7():44-6. PubMed ID: 3104657
[TBL] [Abstract][Full Text] [Related]
40. Different dosage regimens of ranitidine in the short-term therapy of duodenal ulcer: a multicentre trial.
Castelli G; Squassante L; Uleri S; Zanferrari G
Int J Clin Pharmacol Res; 1991; 11(1):41-9. PubMed ID: 1874580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]